These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 433175)

  • 21. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.
    Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of hemophilia in Spain.
    Martin-Villar J; Ortega F; Magallon M
    Thromb Haemost; 1976 Jun; 35(3):537-43. PubMed ID: 989959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term treatment of hemophilia A with plasma fractions].
    Mey U; Gaerisch F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):357-62. PubMed ID: 4195282
    [No Abstract]   [Full Text] [Related]  

  • 25. [Electrolyte content of substitution substances containing factor 8 (author's transl)].
    Göbel U; Michaelis E
    Padiatr Padol; 1972; 7(1):50-5. PubMed ID: 4670276
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antihemophilic activity of donor blood].
    Shuruev AS
    Probl Gematol Pereliv Krovi; 1976; 21(9):45-6. PubMed ID: 1005391
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of haemophilia.
    Rizza CR
    Practitioner; 1970 Jun; 204(224):763-72. PubMed ID: 5452203
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 30. [Epidemiology and characteristics of hemophilia in Bulgaria].
    Anastassov A; Tankovski I; Nigno C; Guénova V; Lissitchkov T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):113-8. PubMed ID: 4110776
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prophylactic replacement therapy in hemophilia. A case report (author's transl)].
    Mitterstieler G
    Padiatr Padol; 1976; 11(2-2):469-74. PubMed ID: 967509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of haemophilia with purified factor 8 (FI-O-Ta).
    de Tezanos Pinto M
    Hemostase; 1966; 6(1):65-71. PubMed ID: 5911788
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimation of the probability of post transfusion hepatitis in hemophilia treatment.
    Davis CE; Grizzle JE; Bryan JA
    Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemophilia: the blood bank's concern?].
    Smit Sibinga CT
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
    [No Abstract]   [Full Text] [Related]  

  • 35. [Proceedings: Therapy of hemophilia A and B].
    Mannucci PM
    Minerva Pediatr; 1973 Dec; 25(42):1889-905. PubMed ID: 4359559
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification and clinical evaluation of a factor 8 concentrate.
    Johnson AJ; Karpatkin MH; Newman J
    Bibl Haematol; 1970; 34():30-9. PubMed ID: 5436351
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties].
    Lopaciuk S; Naleczyńska A; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):826-9. PubMed ID: 5802316
    [No Abstract]   [Full Text] [Related]  

  • 38. Haemophilia.
    Dormandy KM; Currey HL
    Rep Rheum Dis; 1970 Oct; 42():1-2. PubMed ID: 5493731
    [No Abstract]   [Full Text] [Related]  

  • 39. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia.
    Kwa SB; Chen YF
    Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of neonatal hemophilia A with massive subneural hemorrhage].
    Barbero S; Cordero A; Domeneghetti G; Giaccardi A; Sardi R; Serra A
    Minerva Pediatr; 1980 Jun; 32(12):815-7. PubMed ID: 6780779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.